Bruker (NASDAQ:BRKR) Updates FY24 Earnings Guidance

Bruker (NASDAQ:BRKR) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $2.36-2.41 for the period, compared to the consensus estimate of $2.59. The company issued revenue guidance of $3.34-3.37 billion, compared to the consensus revenue estimate of $3.40 billion. Bruker also updated its FY 2024 guidance to 2.360-2.410 EPS.

Wall Street Analyst Weigh In

BRKR has been the subject of several analyst reports. Wells Fargo & Company cut their price target on Bruker from $78.00 to $75.00 and set an “overweight” rating for the company in a report on Wednesday. Citigroup dropped their target price on Bruker from $80.00 to $75.00 and set a “buy” rating for the company in a research note on Wednesday. Barclays decreased their price target on Bruker from $75.00 to $69.00 and set an “overweight” rating on the stock in a research note on Wednesday. Wolfe Research downgraded shares of Bruker from an “outperform” rating to a “peer perform” rating in a research note on Monday, September 30th. Finally, TD Cowen decreased their target price on shares of Bruker from $72.00 to $70.00 and set a “hold” rating on the stock in a research report on Wednesday. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and seven have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $79.36.

Bruker Trading Up 2.6 %

Shares of Bruker stock traded up $1.51 during trading hours on Thursday, hitting $60.49. The company’s stock had a trading volume of 1,346,609 shares, compared to its average volume of 1,264,657. The business has a fifty day moving average of $63.97 and a 200 day moving average of $66.51. Bruker has a 1-year low of $54.55 and a 1-year high of $94.86. The company has a quick ratio of 0.75, a current ratio of 1.65 and a debt-to-equity ratio of 1.18. The company has a market capitalization of $9.16 billion, a PE ratio of 25.10, a P/E/G ratio of 2.32 and a beta of 1.20.

Bruker (NASDAQ:BRKR) last announced its quarterly earnings results on Tuesday, November 5th. The medical research company reported $0.60 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.61 by ($0.01). The company had revenue of $864.40 million during the quarter, compared to analyst estimates of $866.46 million. Bruker had a net margin of 11.29% and a return on equity of 24.92%. The firm’s revenue for the quarter was up 16.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.74 earnings per share. As a group, equities analysts forecast that Bruker will post 2.61 EPS for the current year.

Bruker Company Profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.